Novavax, Inc.
NVAX
$7.95
-$0.43-5.13%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.50% | -79.66% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.50% | -79.66% | |||
| Cost of Revenue | -18.86% | -3.28% | |||
| Gross Profit | 50.26% | -123.90% | |||
| SG&A Expenses | 9.55% | -33.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.25% | -15.41% | |||
| Operating Income | 3.34% | -180.09% | |||
| Income Before Tax | 39.85% | -174.33% | |||
| Income Tax Expenses | 821.80% | -146.80% | |||
| Earnings from Continuing Operations | 33.20% | -174.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.20% | -174.70% | |||
| EBIT | 3.34% | -180.09% | |||
| EBITDA | 3.55% | -167.61% | |||
| EPS Basic | 33.28% | -169.25% | |||
| Normalized Basic EPS | -1.41% | -166.10% | |||
| EPS Diluted | 33.28% | -176.19% | |||
| Normalized Diluted EPS | -1.41% | -173.88% | |||
| Average Basic Shares Outstanding | 0.12% | 7.86% | |||
| Average Diluted Shares Outstanding | 0.12% | -3.50% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
